Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $76.11 in the prior trading day, Haemonetics Corp. (NYSE: HAE) closed at $74.45, down -2.18%. In other words, the price has decreased by -$2.18 from its previous closing price. On the day, 0.58 million shares were traded. HAE stock price reached its highest trading level at $75.84 during the session, while it also had its lowest trading level at $73.995.
Ratios:
Our goal is to gain a better understanding of HAE by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.23. For the most recent quarter (mrq), Quick Ratio is recorded 2.33 and its Current Ratio is at 3.76. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, CL King on September 13, 2024, initiated with a Buy rating and assigned the stock a target price of $116.
On September 11, 2024, BofA Securities started tracking the stock assigning a Neutral rating and target price of $85.
On September 10, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $112.BTIG Research initiated its Buy rating on September 10, 2024, with a $112 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 26 ’24 when Strong Stewart W sold 4,312 shares for $91.15 per share. The transaction valued at 393,039 led to the insider holds 18,196 shares of the business.
Strong Stewart W bought 4,312 shares of HAE for $393,039 on Jul 26 ’24. On Jul 11 ’24, another insider, Lingamneni Anila, who serves as the EVP, Chief Technology Officer of the company, sold 2,136 shares for $90.00 each. As a result, the insider received 192,240 and left with 21,410 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HAE now has a Market Capitalization of 3810179584 and an Enterprise Value of 4845821440. As of this moment, Haemonetics’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.35, and their Forward P/E ratio for the next fiscal year is 13.75. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.86 while its Price-to-Book (P/B) ratio in mrq is 4.21. Its current Enterprise Value per Revenue stands at 3.633 whereas that against EBITDA is 15.429.
Stock Price History:
Over the past 52 weeks, HAE has reached a high of $97.97, while it has fallen to a 52-week low of $70.74. The 50-Day Moving Average of the stock is -3.22%, while the 200-Day Moving Average is calculated to be -9.56%.
Shares Statistics:
The stock has traded on average 575.56K shares per day over the past 3-months and 533980 shares per day over the last 10 days, according to various share statistics. A total of 50.79M shares are outstanding, with a floating share count of 50.61M. Insiders hold about 1.10% of the company’s shares, while institutions hold 109.86% stake in the company. Shares short for HAE as of 1727654400 were 5424452 with a Short Ratio of 9.42, compared to 1724976000 on 6091612. Therefore, it implies a Short% of Shares Outstanding of 5424452 and a Short% of Float of 16.580000000000002.
